NX-5948 assigned the nonproprietary name“bexobrutideg”U.S. FDA Orphan Drug Designation granted to bexobrutideg for the treatment of Waldenströ ...

Results from Phase II studies demonstrated that rilzabrutinib showed clinically meaningful outcomes in patients with warm ...

Cullinan Therapeutics rebranded from oncology to immunology+oncology, focusing on CD19 TCEs for autoimmune diseases. Check ...

Vertex continues to capitalize on its leadership in cystic fibrosis (CF) treatments, where its blockbuster drug Trikafta is ...

Buying a smartphone on a budget can be pretty confusing, especially since brands tend to focus... The post Best Phones Under ...

Shadow Paymaster General Richard Holden has expressed serious concerns about recent stock market declines following the ...

Trump's social media company filed paperwork with the Securities and Exchange Commission that could allow the president's ...

A precision medicine workflow integrating proteomics and personalized xenograft models was developed and applied to an ...

Vertex halts VX-264 trials after missing efficacy goals but continues advancing zimislecel, a potential treatment for severe ...

Netlify/Decap CMS alternative. Fast, lightweight, Git-based headless CMS. Modern UX, first-class i18n support + 100s of improvements. Open source & free. Made with Svelte.

CD20 is a CD marker—a molecule on the cell surface that can be used to identify and type a particular cell in the body. CD20 is found on the surface of B cells (a type of immune system cell). But ...